The UK is meeting the key milestone of vaccination and securing more supplies

Photographer: Anthony Devlin / Bloomberg

The UK will confirm that residents of all eligible care homes in England have been offered a Covid-19 vaccine, even when a dispute over European exports raises concerns about supplies.

Shootings have been offered to eligible residents of more than 10,000 homes, whenever possible, according to official data. The announcement comes after yesterday’s assurances from International Trade Secretary Liz Truss that the country’s supply of vaccines is safe and that the country will follow its deployment schedule.

The UK aims to offer vaccines to around 15 million people in its four main priority groups by 15 February, which include nursing home residents, people over the age of 70, front-line health workers and clinically extremely vulnerable people. So far, a total of 8,977.32 people have received their first dose, with a record number of nearly 600,000 people being captured on Saturday alone, according to government data.

Prime Minister Boris Johnson described nursing home figures as “a crucial milestone in our ongoing race to vaccinate the most vulnerable.” However, he warned that the number of cases and people in the hospital remains dangerously high. More than 100,000 people have died in the UK after testing positive for the virus.

Among those hospitalized with Covid is Captain Tom Moore, the 100-year veteran who has raised nearly £ 40 million ($ 55 million) for the country’s health service.

The UK expanded its vaccine pipeline on Monday by exercising one option to order another 40 million doses of Valneva SE, bringing the total to 100 million doses. According to Valneva, the UK has an option for another 90 million doses between 2023 and 2025 valued the total of 190 million doses at up to 1.4 billion euros ($ 1.7 billion).

The government is “absolutely sure” it can continue delivering its vaccination plan, Truss said Sunday in Sky News. His comments came after the European Union’s executive arm announced it would require manufacturers to obtain authorization before sending features made on the block to some other countries. This raised concerns about the supply of supplies from Pfizer Inc. and BioNTech SE shot, made in Belgium, UK.

Row of vaccines

The source of the dispute is AstraZeneca Plc’s decision to prioritize Britain over the EU after a Belgian production problem, in which Brussels claims it was a breach of contract. After a great activity, AstraZeneca agreed to deliver an additional 9 million doses of vaccine to the EU during the first quarter of this year, bringing the total to 40 million during the period, European Commission President Ursula von der said on Twitter on Sunday Leyen.

Read more: Faced with a vaccine emergency, the EU became an enemy of everyone